Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study

Télécharger : Article

Hervé Léna,Laurent Greillier, Claire Cropet,Olivier Bylicki, Isabelle Monnet,Clarisse Audigier-Valette, Lionel Falchero, Alain Vergnenègre, Pierre Demontrond, Margaux Geier, Florian Guisier, Stéphane Hominal, Chrystèle Locher, Romain Corre, Christos Chouaid, Charles Ricordel, for the GFPC 08–2015 ENERGY investigators*

 

A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study)

Lien : https://doi.org/10.1016/j.lungcan.2024.107866

Télécharger : Article

Mathilde Jacob, Pierre Fournel, Claire Tissot, Jacques Cadranel, Olivier Bylicki, Isabelle Monnet, Grégoire Justeau, Charles Ricordel, Pascal Thomas, Lionel Falchero, Chrystel Locher, Marie Wislez, Alain Vergnenegre, Samir Abdiche, Floran Guisier, Acya Bizieux, Regine Lamy, Geraldine François, Gonzagues De Chabot, Thomas Pierret, Marie Sabatini, Marion Abeillera, Sabine Vieillot, Stephanie Martinez, Hugues Morel, Hélène Doubre, Anne Madroszyk, Margaux Geier, Jean-Luc Labourey, Christos Chouaïd, Laurent Greillier

 

Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial

Lien : https://doi.org/10.1016/j.lungcan.2024.107866

Télécharger : Article
Olivier Bylicki, Florian Guisier, Arnaud Scherpereel, Catherine Daniel, Aurélie Swalduz, Emmanuel Grolleau, Marie Bernardi, Stephane Hominal, Jean-Briac Prevost, Guillaume Pamart, Marie-Hélène Marques, Nicolas Cloarec, Simon Deshayes, Judith Raimbourg, Rémi Veillon, Youssef Oulkhouir, Clarisse Audigier Valette, Fabien Subtil, Christos Chouaïd, Laurent Greillier, on behalf of the GFPC

 

Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France

Lien : doi.org/10.2147/OTT.S448909

Télécharger : Article

Mateo Sanchis-Borja, Florian Guisier, Aurélie Swalduz, Hubert Curcio, Victor Basse, Christophe Maritaz, Christos Chouaid, Jean-Bernard Auliac

 

Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort

Lien : 10.3390/curroncol31030126

Télécharger : Nannini

Simon Nannini, Florian Guisier, Hubert Curcio, Charles Ricordel, Pierre Demontrond, Safa Abdallahoui, Seyyid Baloglu, Laurent Greillier, Christos Chouaid, Roland Schott 

 

 

Resected EGFR-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study)

Lien : 10.1177/17588359241236451

Télécharger : Exerposarticle

Jean-Bernard Auliac, Pascal-Alexandre Thomas, Olivier Bylicki, Florian Guisier, Hubert Curcio, AlainVegnenègre, Aurelie Swalduz, Marie Wislez, Jacques Le Treut, Chantal Decroisette, Victor Basse, Lionel Falchero, Gonzague De Chabot, Diane Moreau, Eric Huchot, Audrey Lupo Mansuet, Helene Blons, Christos Chouaïd, Laurent Greillier